{"DataElement":{"publicId":"2180738","version":"1","preferredName":"Lymphoma Progression Criteria Type","preferredDefinition":"the report of evidence indicating advance or progression of lymphoma disease in a patient as defined by standard criteria to evaluate disease response to treatment as indicated per protocol.","longName":"LYMPH_PROG_CRITER_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195862","version":"1","preferredName":"Lymphoma Progression Criteria","preferredDefinition":"information related to the progression criteria of a lymphoma.","longName":"LYMPHO_PROG_CRITERIA","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206904","version":"1","preferredName":"Lymphoma Progression","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003:Progression; advancement in extent or severity.","longName":"C3208:C25331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progression","conceptCode":"C25331","definition":"Progression; advancement in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0E9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177605","version":"1","preferredName":"Criteria","preferredDefinition":"Criteria; a basis for comparison; a reference point against which other things can be evaluated.","longName":"Criteria","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51B5-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF636A9-999C-54D0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180737","version":"1","preferredName":"Lymphoma Progression Criteria Type","preferredDefinition":"information related to lymphoma progression criteria type.","longName":"LYMPH_PROG_CRITER_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D221D99F-328B-037C-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Increase by >=50% in the size of previously involved sites","valueDescription":"Increase by >=50% in the size of previously involved sites","ValueMeaning":{"publicId":"2568400","version":"1","preferredName":"Increase by >=50% in the size of previously involved sites","longName":"2568400","preferredDefinition":"Increase by >=50% in the size of previously involved sites","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D83D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-10","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3056322-9A8C-3A85-E034-0003BA12F5E7","beginDate":"2004-02-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Increase by >=50% from nadir in the Sum of the Products of Greatest Diameters of any previously identified abnormal node for partial or non-responders","valueDescription":"Increase by >=50% from nadir in the Sum of the Products of Greatest Diameters of any previously identified abnormal node for partial or non-responders","ValueMeaning":{"publicId":"2568401","version":"1","preferredName":"Increase by >=50% from nadir in the Sum of the Products of Greatest Diameters of any previously identified abnormal node for partial or non-responders","longName":"2568401","preferredDefinition":"Increase by >=50% from nadir in the Sum of the Products of Greatest Diameters of any previously identified abnormal node for partial or non-responders","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D83E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-10","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3056322-9A90-3A85-E034-0003BA12F5E7","beginDate":"2004-02-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Appearance of one or more new lesions","valueDescription":"appearance of one or more new lesions","ValueMeaning":{"publicId":"2568261","version":"1","preferredName":"appearance of one or more new lesions","longName":"2568261","preferredDefinition":"appearance of one or more new lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7B2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3056322-9A94-3A85-E034-0003BA12F5E7","beginDate":"2004-02-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-10","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D221CDFC-2181-035B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"MAESKEB","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811962","version":"1","longName":"Response","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Progressive Disease for Lymphoma","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D221CDFC-2185-035B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-30","modifiedBy":"CAMPBELB","dateModified":"2005-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}